Study compares immune responses from three major COVID-19 vaccine types

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
TipRanks on MSN

MRNA, NVAX, BNTX: Here’s What Triggered a Sell-off in Major Vaccine Stocks Today

The memo, written by FDA chief medical and scientific officer Vinay Prasad, reviewed 96 pediatric deaths and concluded that ...
ABC7

Technology used to make COVID vaccines tested to treat HIV, cancer, more

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

COVID Vaccine Tech May Reduce Disabilities in Snakebite Victims

According to researchers, the adapted treatment could help to prevent muscle damage and permanent physical impacts.
Fierce Biotech

Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...